Toll Free: 1-888-928-9744

DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2016 Update

Published: Mar 22, 2016 | Pages: 41 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

DexCom, Inc. (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company's major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom's in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company DexCom, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents 
Table of Contents 2
List of Tables  4
List of Figures  6
DexCom, Inc. Company Snapshot  7
DexCom, Inc. Company Overview  7
DexCom, Inc. Pipeline Products and Clinical Trials Overview  8
DexCom, Inc. - Pipeline Analysis Overview  10
Business Description  10
Key Facts  11
DexCom, Inc. - Major Products and Services  12
DexCom, Inc. Pipeline Products by Development Stage  13
DexCom, Inc. Clinical Trials by Trial Status  15
DexCom, Inc. Pipeline Products Overview  18
DexCom CGM With Accu-Chek Insulin Delivery System  18
DexCom CGM With Accu-Chek Insulin Delivery System Product Overview  18
Dexcom G4 PLATINUM Continuous Glucose Monitor  19
Dexcom G4 PLATINUM Continuous Glucose Monitor Product Overview  19
Dexcom G4 PLATINUM Continuous Glucose Monitor Clinical Trial  20
GlucoClear  26
GlucoClear Product Overview  26
GlucoClear - Second Generation  27
GlucoClear - Second Generation Product Overview  27
GlucoClear - Second Generation Clinical Trial  28
Next-Generation Continuous Glucose Monitoring (CGM) Device  29
Next-Generation Continuous Glucose Monitoring (CGM) Device Product Overview  29
DexCom, Inc. - Key Competitors  30
DexCom, Inc. - Key Employees  31
DexCom, Inc. - Key Employee Biographies  32
DexCom, Inc. - Locations And Subsidiaries  33
Head Office  33
Other Locations & Subsidiaries  33
Recent Developments  34
DexCom, Inc., Recent Developments  34
Mar 14, 2016: Dexcom G5 Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch  34
Mar 09, 2016: Dexcom continuous glucose monitor receivers  34
Feb 23, 2016: DexCom Reports Fourth Quarter and Full Year 2015 Financial Results  35
Dec 27, 2015: Continuous glucose monitoring device DEXCOM G4 PLATINUM now available in GCC through Julphar  36
Nov 04, 2015: DexCom Reports Third Quarter 2015 Financial Results  36
Oct 14, 2015: DexCom Reports Preliminary Third Quarter Revenues  37
Sep 14, 2015: Dexcom G5 Mobile Continuous Glucose Monitoring System Receives CE Mark  37
Sep 14, 2015: Diasend Strengthens Partnership With Dexcom to Seamlessly Sync Mobile Continuous Glucose Meter (CGM) Data for Patients and Healthcare Providers on the Go  38
Aug 24, 2015: FDA Approves Dexcom G5 Mobile Continuous Glucose Monitoring System  38
Aug 05, 2015: DexCom Reports Second Quarter 2015 Financial Results  39
Appendix  41
Methodology  41
About GlobalData  41
Contact Us  41
Disclaimer  41
List of Tables
DexCom, Inc. Pipeline Products and Clinical Trials Overview  8
DexCom, Inc. Pipeline Products by Equipment Type  8
DexCom, Inc. Pipeline Products by Indication  9
DexCom, Inc. Clinical Trials by Trial Status  9
DexCom, Inc., Key Facts  11
DexCom, Inc., Major Products and Services  12
DexCom, Inc. Number of Pipeline Products by Development Stage  13
DexCom, Inc. Pipeline Products Summary by Development Stage  14
DexCom, Inc. Clinical Trials by Trial Status  15
DexCom, Inc. Clinical Trials Summary  16
DexCom CGM With Accu-Chek Insulin Delivery System - Product Status  18
DexCom CGM With Accu-Chek Insulin Delivery System - Product Description  18
Dexcom G4 PLATINUM Continuous Glucose Monitor - Product Status  19
Dexcom G4 PLATINUM Continuous Glucose Monitor - Product Description  19
Dexcom G4 PLATINUM Continuous Glucose Monitor - A Randomized Trial Comparing Continuous Glucose Monitoring with and without Routine Blood Glucose Monitoring in Adults with Type 1 Diabetes  20
Dexcom G4 PLATINUM Continuous Glucose Monitor - A Randomized Trial of the Effect of Continuous Glucose Monitoring (CGM) in Individuals with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (MDI)  20
Dexcom G4 PLATINUM Continuous Glucose Monitor - A Single-blind, Randomized, Two-way, Cross-over Study to Examine the Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation Combined with a Simplified Qualitative Meal-size Estimation in Adults with Type 1 Diabetes  21
Dexcom G4 PLATINUM Continuous Glucose Monitor - A Single-center, Prospective, Open-label, Investigator-initiated Pilot Study Evaluating the Role of Continuous Glucose Monitor (CGM) Use Either Alone or with Remote Monitoring Capabilities  21
Dexcom G4 PLATINUM Continuous Glucose Monitor - Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes  22
Dexcom G4 PLATINUM Continuous Glucose Monitor - At Home Study of a Zone-model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) with the Diabetes Assistant (DiAs) System and Run-to-run Adaptation  22
Dexcom G4 PLATINUM Continuous Glucose Monitor - Continuous Glucose Monitoring During and after Surgery  22
Dexcom G4 PLATINUM Continuous Glucose Monitor - Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) with the Diabetes Assistant (DiAS) in the Outpatient Setting  23
Dexcom G4 PLATINUM Continuous Glucose Monitor - Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects  23
Dexcom G4 PLATINUM Continuous Glucose Monitor - Long-term Effects of Continuous Glucose Monitoring in Patients with Type 1 Diabetes Treated with Multiple Daily Insulin Injections - Extension of CGMMDI Trial  24
Dexcom G4 PLATINUM Continuous Glucose Monitor - Predicting Hypoglycaemia and Arrythmias in the Vulnerable Patient with Diabetes and Chronic Kidney Disease  24
Dexcom G4 PLATINUM Continuous Glucose Monitor - Real-time Continuous Glucose Monitoring (RT-CGM) in Patients with Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)  25
Dexcom G4 PLATINUM Continuous Glucose Monitor - Use of Zone-Model Predictive Control (MPC) Controller on the Diabetes Assistant (DiAs) Platform with Fault Detection in Adolescents with Type 1 Diabetes in the Outpatient Setting (UCSB Study)  25
GlucoClear - Product Status  26
GlucoClear - Product Description  26
GlucoClear - Second Generation - Product Status  27
GlucoClear - Second Generation - Product Description  27
GlucoClear - Second Generation - Pilot Observation of Continuous Glucose Monitoring in Critically Ill Patients Under Consideration of Accuracy, Feasibility and Acceptance by Ward Staff  28
Next-Generation Continuous Glucose Monitoring (CGM) Device - Product Status  29
Next-Generation Continuous Glucose Monitoring (CGM) Device - Product Description  29
DexCom, Inc., Key Employees  31
DexCom, Inc., Key Employee Biographies  32
DexCom, Inc., Subsidiaries  33 


List of Figures
DexCom, Inc. Pipeline Products by Equipment Type  9
DexCom, Inc. Pipeline Products by Development Stage  13
DexCom, Inc. Clinical Trials by Trial Status  15

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify